Choosing small assay kits that answer a specific question: why a glucose assay kit, an ldh assay kit and a glutamate assay kit each report a different thing about a culture and why a released enzyme is a damage readout rather than a metabolite one, how an endotoxin assay, an endotoxin test kit, an endotoxin testing kit, an endotoxin assay kit and a gel clot endotoxin test differ in whether they give a number or a threshold, what inhibition and enhancement testing must show before any endotoxin result is valid, where a mycoplasma test kit, a mycoplasma testing kit, a mycoplasma pcr test kit, a mycoplasma detection kit pcr, mycoplasma detection pcr, mycoplasma test pcr and a broader cell culture contamination detection kit belong on a schedule rather than in a crisis, what a cell proliferation assay kit measures that a count does not, where immunohistochemistry reagents and an immunohistochemistry kit are a system rather than a reagent, what a luminescence reader and a luminometer plate contribute to any of them, and what red fluorescent protein and aav quantification kits are for

Small kits are bought to answer a question in an afternoon, and they do that well inside their assumptions. The recurring problems are reading a proxy as the thing itself, running an assay in a matrix it was not validated in, and treating a threshold assay as a quantitative one.

the biosafety manual that decides handling for biological material
BMBL
good laboratory practice for nonclinical studies, 21 CFR
Part 58
the labelling clause behind research use only on a reagent
809.10(c)

The figures in this panel are regulation and standard identifiers, named from the documents themselves and linked below. They are not prices: BioBricks publishes verified prices for synthesis services only, and does not imply a price index it has not measured.

Choosing and validating a small kit

  1. Separate metabolite from damage readouts. A metabolite concentration reports consumption or production. A released intracellular enzyme reports membrane damage. Both are measured in the same supernatant and they answer different questions.
  2. Know whether the endotoxin format gives a number. Gel clot methods give a pass or fail against a threshold; kinetic and chromogenic formats give a concentration. Choosing the wrong one for the decision produces a result that cannot be used.
  3. Run inhibition and enhancement before any sample. A spiked recovery in your own matrix is what shows the assay can see endotoxin in that sample. Without it a low result cannot be distinguished from a suppressed assay.
  4. Keep contamination screening on a schedule. Screening after a surprising result means the affected experiments are already done. New arrivals in quarantine and continuous cultures on a fixed interval is the pattern that works.
  5. Check the matrix and the standard. Every kit is validated in a matrix against a standard. Serum, medium and lysate interfere differently, and a dilution series plus a spiked recovery detects most of it in one plate.

Proxies are fine when named

Nearly every small kit measures a proxy: a released enzyme for damage, a reduced dye for metabolism, a clot for a threshold. Used knowingly they are efficient; described as the thing itself they mislead.

Write the endpoint into the methods rather than the conclusion. It costs a clause and makes the result durable.

One plate settles interference

A matrix blank, a compound only control and a spiked recovery, run once on a new sample type, detect nearly every interference that matters. It fits alongside the first real experiment.

Doing it converts a recurring source of confusion into a documented property of the assay in your hands.

Common questions

Does a released enzyme assay measure toxicity?
It measures membrane damage, which is one late consequence of toxicity. Cells that stop dividing without lysing show nothing, which is why it is paired with a metabolic or count based readout.
Which endotoxin format should I use?
A threshold method where a pass or fail against a limit is the decision, and a kinetic or chromogenic method where a number is needed. Both require inhibition and enhancement testing in your matrix.
How often should mycoplasma be tested?
On arrival in quarantine, and on a fixed interval for cultures in continuous use. Testing only when something looks wrong means the contaminated cultures have already produced data.

Get a shortlist for your project

Free. We send a shortlist of vendors whose published prices and service scope fit what you described, built from the verified index on this site. We may email you about this enquiry and similar services from this site; opt out any time, including from the first message.

Browse by service class

Sources

Cite or embed this figure

The median advertised gene synthesis price per base pair in the US research synthesis services market was $0.11 in August 2026, across 4 verified vendor service pages recorded in BioBricks Synthesis Price Index.

Cite as: "BioBricks Synthesis Price Index", updated 2026-08-24, https://biobricks.org/glucose-assay-kit/.

Embed this figure (plain HTML, no scripts)
median advertised gene synthesis price per base pair · the US research synthesis services market · August 2026

$0.11

Middle 50%$0.07 – $0.15
verified vendor service pages4

Source: BioBricks Synthesis Price Index

Get a vendor shortlistCompare synthesis prices